| Immunogenicity and safety of the CoronaVac vaccine in patients with cancer receiving active systemic therapy C Karacin, T Eren, E Zeynelgil, GI Imamoglu, M Altinbas, I Karadag, ... Future Oncology 17 (33), 4447-4456, 2021 | 38 | 2021 |
| Harmful consequences of COVID-19 fear in patients with cancer O Sutcuoglu, O Yazici, A Ozet, N Ozdemir BMJ supportive & palliative care 13 (e1), e102-e104, 2023 | 24 | 2023 |
| Role of silymarin (Silybum marianum) in the prevention of colistin-induced acute nephrotoxicity in rats B Dumludag, MK Derici, O Sutcuoglu, B Ogut, OT Pasaoglu, II Gonul, ... Drug and chemical toxicology 45 (2), 568-575, 2022 | 16 | 2022 |
| Cachexia index in predicting outcomes among patients receiving immune checkpoint inhibitor treatment for metastatic renal cell carcinoma V Aslan, ACK Kılıç, O Sütcüoğlu, E Eraslan, A Bayrak, B Öksüzoğlu, ... Urologic Oncology: Seminars and Original Investigations 40 (11), 494. e1-494 …, 2022 | 7 | 2022 |
| A possible interaction between favipiravir and methotrexate: Drug-induced hepatotoxicity in a patient with osteosarcoma E Demir, O Sütcüoğlu, B Demir, O Ünsal, O Yazıcı Journal of Oncology Pharmacy Practice 28 (2), 445-448, 2022 | 7 | 2022 |
| Does docetaxel matter in metastatic gastric cancer? FOLFOX versus FLOT regimens as first-line treatment F Gürler, A İlhan, DC Güven, O Turhan, BK İnci, O Sütçüoğlu, F Yildiz, ... Anti-cancer drugs 33 (1), e477-e485, 2022 | 6 | 2022 |
| Evaluation of scientific reliability and quality of YouTube videos on cancer and nutrition O Sütcüoğlu, Zİ Özay, A Özet, O Yazıcı, N Özdemir Nutrition 108, 111933, 2023 | 5 | 2023 |
| Effects of sarcopenia, myosteatosis, and the prognostic nutritional index on survival in stage 2 and 3 gastric cancer patients K Bir Yucel, AC Karabork Kilic, O Sutcuoglu, O Yazıcı, U Aydos, K Kilic, ... Nutrition and Cancer 75 (1), 368-375, 2022 | 5 | 2022 |
| Krukenberg Tumor Presentation of Recurrent Gallbladder Cancer After a Decade B Tuzcu, O Sütcüoğlu, EK Bayram, Ö Erdem, O Yazıcı Journal of Gastrointestinal Cancer, 1-4, 2023 | 4 | 2023 |
| Early local therapy for the primary site in de novo stage IV breast cancer: results of a randomized clinical trial (EA2108) B KILIÇ, O Sütcüoğlu, O Yazici, N Özdemir Journal of Clinical Oncology 40 (33), 2022 | 4 | 2022 |
| Nivolumab–ipilimumab combination therapy-induced seronegative encephalitis; rapid response to steroid plus intravenous immunoglobulin (IVIG) treatment K Bir Yucel, O Sutcuoglu, O Yazıcı, Y Yıldız, E Şenol, A Uner Journal of Oncology Pharmacy Practice 29 (3), 760-763, 2023 | 3 | 2023 |
| Greater financial toxicity correlates with increased psychological distress and lower quality of life among Turkish cancer patients KB Yücel, ZI Özay, O Sütcüoğlu, O Yazıcı, A Üner, N Günel, A Özet, ... Supportive Care in Cancer 31 (2), 137, 2023 | 3 | 2023 |
| Interpretation of the OPRA study: are our criteria reliable enough to recommend watch and wait? O Sütcüoğlu, N Rustamova Cennet, A Özet, N Özdemir, O Yazıcı Journal of Clinical Oncology 41 (2), 416-417, 2023 | 3 | 2023 |
| Effect of neoadjuvant therapy on tumor tissue PD-L1 and VISTA expression levels in non-small-cell lung cancer O Akdoğan, O Sütcüoğlu, B Öğüt, N Akyürek, N Özdemir, A Özet, O Yazıcı Immunotherapy 14 (14), 1121-1131, 2022 | 3 | 2022 |
| Current status of biosimilars in Turkey: a survey among medical oncologists F Gürler, DD Kasım, B Kurt İnci, O Sütçüoğlu, O Ünsal, V Aslan, G Tahtacı, ... Journal of Oncology Pharmacy Practice 28 (7), 1516-1523, 2022 | 3 | 2022 |
| Thirty-day mortality rates after immunotherapy initiation O Sütcüoğlu, A İlhan, SY Tacar, DC Güven, G Uçar, N Karadurmuş, ... Immunotherapy 13 (17), 1419-1426, 2021 | 3 | 2021 |
| Is it possible to prevent contrast-induced nephropathy with dexpanthenol? O Sutcuoglu, MK Derici, OT Pasaoglu, B Dumludag, O Helvacı, B Ogut, ... International urology and nephrology 51, 1387-1394, 2019 | 3 | 2019 |
| Primary renal neuroendocrine carcinoma: Diagnosis and treatment dilemmas A Ciltas, O Sütçüoğlu, R Civelek, M Benekli Journal of Cancer Research and Therapeutics 14 (6), 1444-1445, 2018 | 3 | 2018 |
| Is it necessary to measure basal serum lipid levels in cancer patients prior to tamoxifen treatment? O Sütcüoğlu, O Yazıcı, A Özet Future Oncology 17 (35), 4823-4825, 2021 | 2 | 2021 |
| Otoimmün Hepatit Hastalarında Tek Merkez Tedavi Deneyimi. O Sütçüoğlu, ZG Sargın, NA Haghighi, SD Yüceldi, A Karataş, İK Önal, ... Gazi Medical Journal 28 (3), 2017 | 2 | 2017 |
Ahmet OZETGazi Tıpgazi.edu.tr üzerinde doğrulanmış e-posta adresine sahip
